Argonaut Introduces Camile Connection for Easier Integration of Lab Instruments.Business Editors and Health/Medical Writers FOSTER CITY, Calif.--(BW HealthWire)--Nov. 26, 2001 Argonaut Technologies, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AGNT AGNT Association for Global New Thought AGNT Agent Table ) announced today the addition of Camile Connection(TM) to its line of process control solutions that allow pharmaceutical and chemical companies to automate and precisely control chemical process development. Camile Connection is a flexible, easy-to-use distributed control system A distributed control system (DCS) refers to a control system usually of a manufacturing system, process or any kind of dynamic system, in which the controller elements are not central in location (like the brain) but are distributed throughout the system with each component that efficiently integrates control of all lab devices. Camile Connection has a scalable architecture that allows the user from a central vantage point to specify the control and acquisition capabilities on a single reactor or on multiple reactors. "In today's laboratory, a top priority is to efficiently utilize and monitor process instrumentation as researchers scale-up the production of new chemicals," stated Lissa Goldenstein, Argonaut president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Camile Connection allows scientists to gather important information on the progress of reactions and to dynamically alter the measurement parameters, as well as quickly determine if the best instrumentation is being used. Camile Connection's open architecture and modular design In the context of systems engineering, modular design — or "modularity in design" — is an approach aiming to subdivide a system into smaller parts (modules) that can be independently created and then used in different systems to drive multiple functionalities. makes modification and customization of complex laboratory experiments simple, reducing the incremental costs Costs which are additional costs to the Service appropriations that would not have been incurred absent support of the contingency operation. See also financial management. of adding devices or additional measurement requirements." Camile Connection is compatible with existing installations allowing for easy expansion for current customers. The Camile Connection will serve as the process control foundation for future Argonaut products. Argonaut Technologies Argonaut Technologies, Inc. is a pioneer in the development of innovative products that speed and simplify how chemists discover and develop new chemical entities. Our products enable chemists to increase their productivity, reduce their operating costs through automation and process simplification, achieve faster time-to-market for new products, and cost-effectively explore the increasing number of drug targets available for drug development. We provide solutions that are used in over 825 pharmaceutical, chemical and academic laboratories worldwide. Our instruments, software and consumables for chemistry enable chemists to perform experiments under a variety of conditions in a fraction of the time and cost of traditional methods. Forward Looking Statements Statements included in this press release that are not historical in nature may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Examples of such forward-looking statements include, without limitation, statements regarding a new process chemistry system or any new instruments or tools, any benefits for customers to be derived from new instruments or tools, and the ability of Argonaut's products to enhance chemical development or achieve market acceptance. Any such forward-looking statements involve risks and uncertainties and reflect Argonaut's judgment as of the date of this release. These and other risk factors are discussed in Argonaut's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2000 filed on April 2, 2001, as amended, in its most recent quarterly report on Form 10-Q Form 10-Q See 10-Q. for the quarter ended September 30, 2001 filed on November 13, 2001, and its other filings with the Securities and Exchange Commission. Argonaut disclaims any intent or obligation to update these forward-looking statements. The Company claims the protection of the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion